FDA grants priority review for Genentech's Tecentriq in stage III dMMR/MSI-H colon cancer

Harbour BioMed IND for HBM7004 accepted by China's NMPA

Organon secures FDA approval expanding TOFIDENCE indications for CRS and paediatric COVID-19

Sanofi halts phase 3 MOBILIZE study of riliprubart in CIDP

Lynk Pharmaceuticals' partner Formation Bio doses first participant in BLKR201 Phase 1 trial

Verge Labs and Tenacia Biotechnology collaborate on advancing Tenacia's CNS pipeline

FDA grants rare paediatric disease designation to RedHill's opaganib

Bavarian Nordic secures DKK700m government vaccine contract

GSK to acquire Nuvalent for USD10.6bn to expand lung cancer portfolio

Adcentrx Therapeutics' ADRX-0405 granted Chinese regulatory IND clearance to treat late-stage solid tumours

Argo Biopharma to present updated BW-20805 Phase II results at EAACI 2026 Congress

Curasight reports encouraging preliminary Phase 1 data for uTREAT in glioblastoma

Sciwind Biosciences reports positive study data on ecnoglutide versus semaglutide

Antengene presents first ATG-207 preclinical data at EULAR 2026

OriCell's GPC3 CAR-T Phase II hepatocellular carcinoma trial receives Chinese regulatory clearance